Additional Data available

NASDAQ Biotechnology (NBI)

The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.

The Index began on November 1, 1993 at a base value of 200.00.

Last Updated: 9/17/2021

Summary

Last 5,391.63
Net Change 31.66
Net Change(%) 0.59
Day High 5,394.66
Day Low 5,294.53
Previous Close 5,391.63
Base Value 200.00

Quick Facts

# of Components 267
Index Currency USD
Entitlement U.S. Classic (NASDAQ / PHLX)

Related Links

Products for NASDAQ Biotechnology Index

ETF

Name Symbol Sponsor
ProShares Ultra NASDAQ Biotechnology ETF BIB ProShares Trust
ProShares UltraShort NASDAQ Biotechnology ETF BIS ProShares Trust
Invesco Nasdaq Biotechnology ETF IBBQ Invesco
Invesco NASDAQ Biotech UCITS ETF SBIO Invesco PowerShares
Tin'Koff Nasdaq Biotech TBIO Tinkoff Capital
Capital NASDAQ Biotechnology Index Exchang Traded Fund 678 Capital Securities Inv Tst Co.
Mirae Asset TIGER Nasdaq BIO ETF 203780 Mirae Asset MAPS Global Investment Co., Ltd

Fund

Name Symbol Sponsor
KSM ETF (4A) NASDAQ Biotechnology Currency Hedged KSMF168 KSM Mutual Funds Ltd
TachSAL(4A) Comp S&PHealth(70%)NAS BIO(30%) Currency Hedged TCHF53 Meitav Tachlit Mutual Funds Ltd.
Nasdaq Biotechnology Index Mother Fund 04312181- Daiwa Asset Management Co. Ltd.
Tachlit SAL (4A) NASDAQ Biotechnology Currency-Hedged TCHF142 Meitav Tachlit Mutual Funds Ltd.
Tachlit SAL (4D) NASDAQ Biotechnology TCHF80 Meitav Tachlit Mutual Funds Ltd.
Loading...
Account Sign In